Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
23 Nov 2024
Improved Diagnostic Tool for Clear Cell Renal Cell Carcinoma
Diagnostic superiority of [68Ga]Ga-NYM046 PET/CT over the conventional [18F]FDG PET/CT in detecting clear cell renal cell carcinoma
23 Nov 2024
Scoring System Predicts Disease Risk After Stem Cell Transplant in Leukaemia
A study has developed a scoring system to predict the risk of disease recurrence after stem cell transplantation in leukaemia patients
23 Nov 2024
Semaglutide Tops USA Drug Sales Amidst Rising Eligibility and Cost Concerns
In 2023, semaglutide emerged as the top-selling drug in the USA, generating $13.8 billion in sales.
23 Nov 2024
Rare Gene Variant Protects against Type 2 Asthma
This variant results in reduced STAT6 protein levels, dampened IL-4 responses, and lower IgE and eosinophil counts in the blood.
First anti-TFPI for haemophilia approved in EU
Pfizer’s anti-tissue factor pathway inhibitor has been approved for the treatment of haemophilia A & B by the European Commission.
22 Nov 2024
Neoantigen DNA Vaccines Show Promise in Triple-Negative Breast Cancer
Neoantigen DNA vaccines show safety and efficacy in reducing breast cancer recurrence, promising a personalised approach to immunotherapy in high-risk patients.
22 Nov 2024
Kidney Decline: A Key Predictor of Transthyretin Amyloid Cardiomyopathy Mortality
Kidney function decline in ATTR-CM predicts worse outcomes. Monitoring eGFR changes can guide interventions, improving clinical care for this progressive disease.
22 Nov 2024
What Drives Upper Extremity Disability in Early Rheumatoid Arthritis?
Upper extremity disability in rheumatoid arthritis fluctuates over time, with pain and hand function playing a critical role, study finds.
22 Nov 2024
Largest Genetic Study of Epilepsy Reveals New Treatment Targets
This new research sheds light on shared and subtype-specific genetic variations and points to potential targets
22 Nov 2024
Restaging MRI Predicts Outcomes in Locally Advanced Rectal Cancer After Neoadjuvant Therapy
Restaging MRI is a powerful tool for predicting survival and organ preservation in rectal cancer patients after total neoadjuvant therapy…
←
1
2
3
…
162
163
164
165
166
167
168
…
1,111
1,112
1,113
→
We’ve noticed you’re accessing
from
North/South America.
View
View